Mutagenicity and carcinogenicity of topoisomerase-interactive agents
- 1 August 1994
- journal article
- review article
- Published by Elsevier in Mutation Research
- Vol. 309 (1), 109-142
- https://doi.org/10.1016/0027-5107(94)90048-5
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Secondary pre-leukaemia and etoposideThe Lancet, 1991
- Mechanism of quinolone mutagenicity in bacteriaMutation Research, 1991
- Embryotoxicity of the intercalating agents m‐AMSA and o‐AMSA and the epipodophyllotoxin VP‐16 in postimplantation rat embryos in vitroTeratology, 1990
- Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell TumorsNew England Journal of Medicine, 1990
- Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid LeukemiaNew England Journal of Medicine, 1989
- Inhibition of tyrosine protein kinases by the antineoplastic agent adriamycinBiochemical and Biophysical Research Communications, 1989
- Hotspot sites for acridine-induced frameshift mutations in bacteriophage T4 correspond to sites of action of the T4 type II topoisomeraseJournal of Molecular Biology, 1988
- Adriamycin and daunomycin induce interstrand DNA crosslinks in HeLa S3 cellsBiochemical and Biophysical Research Communications, 1983
- Acute leukemia in pregnancy. Successful delivery after cytarabine and doxorubicinJAMA, 1978
- Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity testMutation Research/Environmental Mutagenesis and Related Subjects, 1975